The effect of dietary modification on multiple sclerosis.

Effect of the dietary modification on the body mass index, body fat percent and clinical manifestations in patients with multiple sclerosis (MS).

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20181113041641N1

Enrollment

160

Registered

2018-11-16

Start date

2018-01-20

Completion date

Unknown

Last updated

2021-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis. Multiple sclerosis

Interventions

Intervention 1: Intervention group: Following a Mediterranean-like diet consist of 17-15% protein with an emphasis on the consumption of fish and seafood, 45-47% carbohydrates with an emphasis on the

Eligibility

Sex/Gender

All

Age

20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Age between 20-60 years Having basic literacy. Writing ability and memory strength Good mental conditions for the continuation of the study

Exclusion criteria

Exclusion criteria: Participating in other interventional studies at the same time. Having the other acute and severe illness Regular and periodic consumption of special dietary supplement or sport-specific diets The full-dose intake of oral corticosteroides Continues and daily cigarette smoking People who are waiting for abdominal surgery

Design outcomes

Primary

Measure	Time frame
Quality of life. Timepoint: At first, three months and six months later (end of intervention). Method of measurement: Multiple Sclerosis Quality Of Life-54 items (MSQOL-54).;Fatigue severity. Timepoint: At first, three months and six months later (end of intervention). Method of measurement: Fatigue Severity Scale-9 items (FSS-9).;Disease activity. Timepoint: At first, three months and six months later (end of intervention). Method of measurement: Extended Disability Status Scale (EDSS).;Number of attacks (Relapse rate). Timepoint: At first, three months and six months later (end of intervention). Method of measurement: Asking the patient by a neurologist.;Body Mass Index (BMI). Timepoint: At first, three months and six months later (end of intervention). Method of measurement: The equation of weight (in kilograms) divided by the square of height (in square meter).;Weight. Timepoint: At first, three months and six months later (end of intervention). Method of measurement: Digital scale.;Body fat percentage. Timepoint: At first, three months and six months later (end of intervention). Method of measurement: Deurenberg Equation.	—

Measure

Time frame

Quality of life. Timepoint: At first, three months and six months later (end of intervention). Method of measurement: Multiple Sclerosis Quality Of Life-54 items (MSQOL-54).;Fatigue severity. Timepoint: At first, three months and six months later (end of intervention). Method of measurement: Fatigue Severity Scale-9 items (FSS-9).;Disease activity. Timepoint: At first, three months and six months later (end of intervention). Method of measurement: Extended Disability Status Scale (EDSS).;Number of attacks (Relapse rate). Timepoint: At first, three months and six months later (end of intervention). Method of measurement: Asking the patient by a neurologist.;Body Mass Index (BMI). Timepoint: At first, three months and six months later (end of intervention). Method of measurement: The equation of weight (in kilograms) divided by the square of height (in square meter).;Weight. Timepoint: At first, three months and six months later (end of intervention). Method of measurement: Digital scale.;Body fat percentage. Timepoint: At first, three months and six months later (end of intervention). Method of measurement: Deurenberg Equation.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAmir Reza Moravejolahkami

Esfahan University of Medical Sciences

a.moravej@mail.mui.ac.ir+98 31 3335 4453

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026